Search research articles
Contact Us
Filters
Showing results (81-90 of 98) with videos related to
Page
of 10
Sort By:
Farmaco (Societa Chimica Italiana : 1989)
|
November 1, 1993
Potential antitumor agents. 23.(1) Cytotoxic and differentiating activity of compounds related to hexamethylenebisacetamide
A Andreani, M Rambaldi, A Locatelli, et al.
Cytotechnology
|
April 8, 2017
Potential neoplastic evolution of Vero cells: in vivo and in vitro characterization
N A Andreani, S Renzi, G Piovani, et al.
Food Microbiology
|
December 8, 2014
Reprint of 'Tracking the blue: a MLST approach to characterise the Pseudomonas fluorescens group'
N A Andreani, M E Martino, L Fasolato, et al.
Nutrients
|
February 25, 2023
Maternal Pea Protein Intake Provides Sex-Specific Protection against Dyslipidemia in Offspring from Obese Pregnancies
Todd C Rideout, Gabriella A Andreani, Jillian Pembroke, et al.
Anti-Cancer Drug Design
|
April 19, 2002
Synthesis and antitumor activity of substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones
A Andreani, M Granaiola, A Leoni, et al.
Food Microbiology
|
January 7, 2014
Tracking the blue: a MLST approach to characterise the Pseudomonas fluorescens group
N A Andreani, M E Martino, L Fasolato, et al.
Il Farmaco; Edizione Scientifica
|
October 1, 1978
[Substances having antiviral activity. IX. Synthesis and antiviral activity of 1-acyl-2-halo-3-formylindole thiosemicarbazones]
A Andreani, D Bonazzi, V Cavrini, et al.
Food Microbiology
|
September 28, 2021
Livestock microbial landscape patterns: Retail poultry microbiomes significantly vary by region and season
B J Schofield, N A Andreani, C S Günther, et al.
International Journal of Food Microbiology
|
November 27, 2022
Molecular typing and genome sequencing allow the identification of persistent Listeria monocytogenes strains and the tracking of the contamination source in food environments
R Lucchini, L Carraro, M Pauletto, et al.
Anti-Cancer Drug Design
|
November 22, 2001
Imidazo[2,1 -b]thiazolylmethylene- and indolylmethylene-2-indolinones: a new class of cyclin-dependent kinase inhibitors. Design, synthesis, and CDK1/cyclin B inhibition
A Andreani, A Cavalli, M Granaiola, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 98) with videos related to
Sort By:
Page
of 10
Farmaco (Societa Chimica Italiana : 1989)
|
November 1, 1993
Potential antitumor agents. 23.(1) Cytotoxic and differentiating activity of compounds related to hexamethylenebisacetamide
A Andreani, M Rambaldi, A Locatelli, et al.
Cytotechnology
|
April 8, 2017
Potential neoplastic evolution of Vero cells: in vivo and in vitro characterization
N A Andreani, S Renzi, G Piovani, et al.
Food Microbiology
|
December 8, 2014
Reprint of 'Tracking the blue: a MLST approach to characterise the Pseudomonas fluorescens group'
N A Andreani, M E Martino, L Fasolato, et al.
Nutrients
|
February 25, 2023
Maternal Pea Protein Intake Provides Sex-Specific Protection against Dyslipidemia in Offspring from Obese Pregnancies
Todd C Rideout, Gabriella A Andreani, Jillian Pembroke, et al.
Anti-Cancer Drug Design
|
April 19, 2002
Synthesis and antitumor activity of substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones
A Andreani, M Granaiola, A Leoni, et al.
Food Microbiology
|
January 7, 2014
Tracking the blue: a MLST approach to characterise the Pseudomonas fluorescens group
N A Andreani, M E Martino, L Fasolato, et al.
Il Farmaco; Edizione Scientifica
|
October 1, 1978
[Substances having antiviral activity. IX. Synthesis and antiviral activity of 1-acyl-2-halo-3-formylindole thiosemicarbazones]
A Andreani, D Bonazzi, V Cavrini, et al.
Food Microbiology
|
September 28, 2021
Livestock microbial landscape patterns: Retail poultry microbiomes significantly vary by region and season
B J Schofield, N A Andreani, C S Günther, et al.
International Journal of Food Microbiology
|
November 27, 2022
Molecular typing and genome sequencing allow the identification of persistent Listeria monocytogenes strains and the tracking of the contamination source in food environments
R Lucchini, L Carraro, M Pauletto, et al.
Anti-Cancer Drug Design
|
November 22, 2001
Imidazo[2,1 -b]thiazolylmethylene- and indolylmethylene-2-indolinones: a new class of cyclin-dependent kinase inhibitors. Design, synthesis, and CDK1/cyclin B inhibition
A Andreani, A Cavalli, M Granaiola, et al.
Page
of 10